DaVita Exceeds Goal for Patient Vaccinations Early in Flu Season
November 07 2011 - 9:00AM
Business Wire
DaVita Inc. (NYSE: DVA), a leading provider of kidney care
services committed to improving the quality of life for those
diagnosed with chronic kidney disease (CKD), announced that the
company has reached its goal of vaccinating 90 percent of its
patient population from the flu this season. According to internal
reporting, at the end of October DaVita’s patient inoculation rate
already was at 90.4 percent.
To reach its 90 percent patient goal, DaVita® teammates
(employees) and attending physicians worked together to educate
patients on the importance of getting a flu shot. DaVita recognizes
the critical need for protection against the virus and therefore
offers the vaccine at no cost to patients.
“I’m thankful for the knowledge and experience of my
caregivers,” said DaVita patient Elaine Tolno at the DaVita Belcaro
Dialysis Facility in Denver, Colo. “They didn’t tell me I had to
get a flu shot; they explained to me why it’s important for
dialysis patients to get vaccinated. Now I’m better informed and
protected.”
Studies have shown that high vaccination rates relate directly
to fewer hospitalizations, which can lead to a better quality of
life for dialysis patients. To combat the spread of the seasonal
flu virus DaVita provides flu vaccines for its patients and
teammates.
“CKD patients are at a higher risk for complications due to the
flu virus,” explained Dr. Allen R. Nissenson, DaVita’s chief
medical officer. “This vaccine not only improves the quality of
patients’ lives – it saves lives.”
According to the Centers for Disease Control and Prevention,
seasonal flu activity can begin as early as October and continue to
occur as late as May. Flu activity most commonly peaks in the U.S.
in January or February. DaVita also encourages anyone who has
physical contact with a dialysis patient to receive a flu
vaccination early in the flu season.
DaVita is a registered trademark of DaVita Inc. All other
trademarks are the property of their respective owners.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease.
DaVita strives to improve patients’ quality of life by innovating
clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services.
As of June 30, 2011, DaVita operated or provided administrative
services at 1,669 dialysis facilities, serving approximately
131,000 patients. DaVita supports numerous programs dedicated to
creating positive, sustainable change in communities around the
world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu. For more information, please
visit www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024